ClinicalTrials.gov
public full text
Public Domain
Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia
A multicenter randomized, double-blind, placebo-controlled clinical trial of Convalescent SARS COVID-19 plasma versus Placebo to evaluate the effect between arms on an ordinal score of six mutually exclusive categories of clinical status at day 30 after study initiation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital#858973
- Investigating a Vaccine Against COVID-19#982378
- Convalescent Plasma for COVID-19 Patients#1228679
- Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)#175006
- A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection#1349409
Record · ID 1210877
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive